Today: 30 June 2026
Figure Technology Solutions stock jumps premarket after Mizuho lifts target, OPEN blockchain push
16 January 2026
1 min read

Figure Technology Solutions stock jumps premarket after Mizuho lifts target, OPEN blockchain push

New York, Jan 16, 2026, 08:40 EST — Premarket

  • Shares jumped roughly 16% in premarket trading, following Thursday’s close at $55.87
  • Mizuho lifted its price target to $64 from $56 while maintaining an Outperform rating
  • This week, the company launched its OPEN on-chain public equity network on Provenance

Figure Technology Solutions (FIGR.O) jumped roughly 16% to $64.96 in premarket on Friday, following Mizuho’s boost of its price target to $64 from $56. The firm kept its Outperform rating on the fintech stock. Since its $25 IPO last September, the shares have surged significantly.

This shift shines a spotlight on a seldom-seen corner of the market: the recording, settlement, and borrowing of shares. That infrastructure is typically slow, centralized, and costly to access.

Figure is pushing ahead regardless. As a fresh face on the market, it’s betting that “market structure” will drive growth instead of just adding to compliance expenses.

Figure announced Wednesday the launch of its On-Chain Public Equity Network, or OPEN, which it claims allows companies to list equity directly on a public blockchain instead of issuing tokens tied to traditional shares. The shares will trade on a limit order book through Figure’s Alternative Trading System, or ATS — a regulated platform that matches buyers and sellers outside a public exchange — enabling continuous trading, the company said.

“OPEN reinvents equity trading,” said Mike Cagney, Figure’s executive chairman, in the company’s announcement. Shareholders will also gain the ability to borrow against and lend out stock via its “Democratized Prime” decentralized finance protocol—DeFi, which covers blockchain-based financial services operating without a central middleman. GlobeNewswire

The company announced plans to be the first issuer using OPEN, aiming to enable two-way exchange between OPEN shares and its Nasdaq-listed stock, allowing liquidity to flow across both platforms. Figure said Jump Trading LLC will handle market-making, while BitGo will provide custody for eligible shareholders. It also revealed it already has a first commitment lined up for the next on-chain issuance.

Yet the stock’s rally hinges on tricky-to-predict factors: the pace at which issuers enter the market, if regulators greenlight wider on-chain issuance, and whether DeFi-based stock lending steers clear of the operational hiccups and risk-management failures that tend to unsettle institutional players.

Traders are waiting on a timetable for Figure’s inaugural OPEN-based issuance and whether additional market makers and issuers step forward. According to Nasdaq data, Figure is set to release earnings on Feb. 12.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Shrem InvIT promoter group cuts stake, sells ₹50.66 crore of units on NSE
    June 29, 2026, 11:16 PM EDT. Satish Venture(S) Global LLP, linked to Shrem InvIT's promoter group, offloaded 45 lakh units on the NSE last week, booking ₹50.66 crore. Shrem Infra Investment Manager said the sales took place on June 25 and June 29 through on-market deals. The stake dropped to 3.97%, down from 4.71%, with Satish Venture holding 2.43 crore units after the selloff. Sale figures don't include taxes and brokerage. The disclosures come as per SEBI insider trading rules.
Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls
Previous Story

Bitcoin price nears $97,000 as ETF inflows rebound and Senate crypto bill stalls

Merck stock slips as FDA fast-track questions build and earnings near
Next Story

Merck stock slips as FDA fast-track questions build and earnings near

Go toTop